Evidence map›Paper›PMID 38927312›Full record

ArticleBiology2024

Using a Combination of Novel Research Tools to Understand Social Interaction in the

Maja Stojkovic, Milan Petrovic, Maria Capovilla, Sara Milojevic, Vedrana Makevic, Dejan B Budimirovic, Louise Corscadden, Shuhan He, Dragana Protic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maja StojkovicDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-0706-3800
Milan PetrovicDepartment of Informatics, University of Rijeka, 51000 Rijeka, Croatia.
Maria CapovillaUMR7275 CNRS-UCA, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Valbonne Sophia Antipolis, France.ORCID 0000-0002-1308-7964
Sara MilojevicDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8280-3015
Vedrana MakevicDepartment of Pathophysiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-3053-7314
Dejan B BudimirovicDepartment of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA.ORCID 0000-0001-7263-5134
Louise CorscaddenMaze Engineers, Skokie, IL 60077, USA.ORCID 0000-0001-5694-4287
Shuhan HeLab of Computer Science, Department of Internal Medicine, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-9902-5077
Dragana ProticDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2137-5405

Funding

Science Fund of the Republic of Serbia Program IDEA, No7673781
6 · The paper itself

Abstract

Fragile X syndrome (FXS), the most common monogenic cause of inherited intellectual disability and autism spectrum disorder, is caused by a full mutation (>200 CGG repeats) in the Fragile X Messenger Ribonucleoprotein 1 (

Indexed as

Drosophila melanogaster model of fragile X syndromeFMR1 genefragile X syndromesocial anxietysocial interactionsocial network analysis

Identifiers

PMID38927312
PMCPMC11200401

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.